[REGN] QoQ Quarter Result on 31-Dec-2022 [#Q4]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
06-Feb-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- -9.01%
YoY- -46.29%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 3,362,700 3,158,100 3,162,100 3,414,400 2,936,200 2,857,200 2,965,100 8.74%
PBT 1,110,800 1,082,900 858,000 1,324,700 1,509,800 963,200 1,061,100 3.09%
Tax 103,000 114,500 40,200 127,600 194,100 111,100 87,600 11.38%
NP 1,007,800 968,400 817,800 1,197,100 1,315,700 852,100 973,500 2.33%
Tax Rate -9.27% -10.57% -4.69% -9.63% -12.86% -11.53% -8.26% -
Total Cost 2,354,900 2,189,700 2,344,300 2,217,300 1,620,500 2,005,100 1,991,600 11.80%
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin 29.97 30.66 25.86 35.06 44.81 29.82 32.83 -5.89%
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
EPS 9.48 9.05 7.64 11.19 11.66 7.47 8.61 6.62%
EPS Diluted 8.89 8.50 7.17 10.50 11.66 7.47 8.61 2.15%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.